NCIC-CTG phase II study of gemcitabine in patients with malignant glioma (IND.94).
Gertler SZ, MacDonald D, Goodyear M, Forsyth P, Stewart DJ, Belanger K, Perry J, Fulton D, Steward W, Wainman N, Seymour L.
Gertler SZ, et al.
Ann Oncol. 2000 Mar;11(3):315-8. doi: 10.1023/a:1008336607135.
Ann Oncol. 2000.
PMID: 10811498
Free article.
Clinical Trial.